Veravas, based in Austin, TX, is revolutionizing laboratory diagnostics with its patented VeraBIND™ technology. By tackling industry challenges and enhancing biomarker detection, Veravas aims to enable early disease detection and improve patient outcomes.
One of Veravas' key solutions is the VeraBIND™ Tau assay, designed for the early detection of tau pathology linked to Alzheimer’s disease. This application underscores the company's commitment to advancing research in crucial areas of diagnosing neurodegenerative diseases.
Veravas offers a range of innovative solutions, including tests and pre-treatment products, to enhance assay sensitivity and ensure reliable biomarker detection. With a focus on sample preparation and result accuracy, Veravas technology supports researchers in accelerating discoveries, conducting liquid biopsies, and enhancing test precision across various diseases and sample types.
Generated from the website content
